BNVI is in the process of making a cup pattern.
BNVI Chart
Bionovo, Inc.
5858 Horton Street
Suite 400
Emeryville, CA 94608
United States - Map
Phone: 510-601-2000
Fax: 510-601-5050
Web Site:
Bionovo: Developing Novel Solutions for Women's Health and Cancer Therapy
DETAILS
Index Membership: N/A
Sector: Healthcare
Industry: Biotechnology
Full Time Employees: 49
BUSINESS SUMMARY
Bionovo, Inc., a clinical stage drug discovery and development company, focuses on womens health and cancer primarily in the United States. Its lead drug candidate, Menerba, is a receptor sub-type selective estrogen receptor modulator for the treatment of vasomotor symptoms of menopause. Bionovo, Inc. also develops Bezielle (formerly BZL101), an oral anti-cancer agent for advanced breast cancer, as well as Seala (formerly VG101), a preclinical drug candidate for the treatment of post-menopausal vulvar and vaginal atrophy. The company was founded in 2002 and is based in Emeryville, California.